You are here: Home » PTI Stories » National » News
Business Standard

Work on largest animal trial facility to begin soon: ICMR

Press Trust of India  |  New Delhi 

The work for building India's largest facility for conducting animal trials will start soon at a 100-acre site in Hyderabad, Director General of Indian Council of Medical Research Soumya Swaminathan said.

The proposal for building the National Animal Research Facility (NARF) at an approximate cost of Rs 350 crore was approved by the Cabinet last month and the work is expected to begin soon, Swaminathan informed.

"The state (Andhra Pradesh) government has allotted 102.69 acres of land at Genome Valley, Hyderabad, free of cost, to the ICMR for establishment of the facility for biomedical research. It will provide India a kind of facility which is lacking at the moment. NARF will be a very advanced institution with all types of animals," she told media.

The research facility will be the first of its kind for quality laboratory animals for basic and applied biomedical research in the country.

"When private or public companies develop a vaccine or a drug they have to go abroad to do the animal study. With NARF like institution, they will be able to do it here then," Swaminathan said.

It will be developed as a world-class facility for breeding and housing of animals such as primates, cabines and other specialised models such as transgenic and knockout rodents required for testing of various research and development products.

The facility will create, develop and provide access to a range of laboratory animals and related technological resources for advancement of biomedical research in the country, mainly to facilitate research in medical colleges, research and academic institutions, universities and biotech and bio-pharma companies.

The facility will also provide training facilities for personnel in specialised areas in the field of biomedical research.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, January 18 2016. 19:13 IST